Drug class
Phosphate Binder
Mechanism of action
Phosphate Chelating Activity [MoA]
General use cases
- Hyperphosphatemia
- serum phosphorus levels in adults and pediatric patients 6 years of age and older with chronic kidney disease (CKD) on dialysis
- serum phosphorus levels in adult and pediatric patients 6 years of age and older with chronic kidney disease on dialysis
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
